SCHEMBL7317569

SCHEMBL7317569

COC(=O)[C@H](Cc1ccc(OCCN2CCCCCC2)cc1)NC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 1/20 0.58
FKBP1A P62942 2/20 0.49
KCNQ1 P51787 2/20 0.48
ITGB1 P05556 2/20 0.47
ITGA5 P08648 2/20 0.47
KMT2A Q03164 1/20 0.47
KCNH2 Q12809 1/20 0.47
HRH3 Q9Y5N1 1/20 0.47
MMP1 P03956 2/20 0.47
MMP3 P08254 1/20 0.47
MMP7 P09237 1/20 0.47
MMP13 P45452 1/20 0.47
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
ADAM17 P78536 1/20 0.46
HCRTR1 O43613 2/20 0.45
HCRTR2 O43614 2/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7511221 0.97 ITGA4 (0.63) ITGA4FKBP1AKCNQ1ITGB1ITGA5
SCHEMBL7327511 0.96 ITGA4 (0.58) ITGA4FKBP1AKCNQ1ITGB1ITGA5
SCHEMBL7508252 0.95 ITGA4 (0.56) ITGA4FKBP1AKCNQ1ITGB1ITGA5
SCHEMBL7315890 0.93 ITGA4 (0.65) ITGA4FKBP1AKCNQ1ITGB1ITGA5
SCHEMBL7317528 0.93 ITGA4 (0.65) ITGA4FKBP1AKCNQ1ITGB1ITGA5
SCHEMBL7314294 0.92 ITGA4 (0.66) ITGA4FKBP1AKCNQ1ITGB1ITGA5
SCHEMBL7318497 0.91 ITGA4 (0.59) ITGA4FKBP1AKCNQ1ITGB1ITGA5
SCHEMBL7510457 0.91 ITGA4 (0.63) ITGA4FKBP1AKCNQ1ITGB1ITGA5
SCHEMBL7316614 0.89 ITGA4 (0.54) ITGA4FKBP1AKCNQ1ITGB1ITGA5
SCHEMBL7318157 0.89 ITGA4 (0.65) ITGA4FKBP1AKCNQ1ITGB1ITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed